Some leading authorities believe lingering issues with the disease stem from residual tissue damage, while others say it comes from lingering issues with the immune system, The Wall Street Journal reported.
The good news stems from recent research out of the Lyme Disease Clinical Research Center at Johns Hopkins University School of Medicine that revealed a biomarker could determine which patients are at higher risk for prolonged issues, The Wall Street Journal said.
Click here to read the full article.
Click here to follow Daily Voice Fairfield and receive free news updates.